Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT05350007
  4. Details
NCT05350007 Clinical Trial

Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age

Cancer Clinical Trial

— CANFRADE  

Official title:
Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05350007
Other study ID # CANFRADE
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 25, 2022
Est. completion date December 31, 2022

Study information
Verified date June 2022
Source Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Contact Elif Yildirim Ayaz, M.D.
Phone +905325148300
Email drelifyildirim@hotmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Description:

No studies were found in the literature evaluating the relationship between frailty and lack of social support with tanatophobia and rumination. The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Recruitment information / eligibility
Status Recruiting
Enrollment 180
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - 65 years or older - Conscious and no communication problems - Being literate - Willing to participate in our study voluntarily - Cancer patient receiving active chemotherapy treatment Exclusion Criteria: - Not being willing to participate in the research - Serious life-threatening condition (critical illness, intensive care unit stay, acute complication) - Dementia, Alzheimer's, cognitive dysfunction - Major psychiatric illness

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Turkey Sultan Abdülhamid Training and Research Hospital Üsküdar Istanbul

Sponsors (1)
Lead Sponsor Collaborator
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Rumination Evaluation of rumination in patients over 65 years of age receiving cancer chemotherapy 1 week
Primary Tanatophobia Evaluation of tanatophobia in patients over 65 years of age receiving cancer chemotherapy 1 week
Secondary fraility Evaluation of fraility in patients over 65 years of age receiving cancer chemotherapy 1 month
Secondary lack of social support Evaluation of lack of social support in patients over 65 years of age receiving cancer chemotherapy 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases